Literature DB >> 34081125

Letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients-a report of the PET/RANO group": 18F-fluciclovine and target volume delineation.

Rupesh Kotecha1,2, Mariam Aboian3, Seyed Ali Nabavizadeh4, Ephraim E Parent5, Daniel M Trifiletti6, Samuel T Chao7.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34081125      PMCID: PMC8328036          DOI: 10.1093/neuonc/noab097

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  5 in total

1.  Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors.

Authors:  Akihide Kondo; Hisato Ishii; Shigeki Aoki; Masaru Suzuki; Hidekazu Nagasawa; Kazuo Kubota; Ryogo Minamimoto; Atsushi Arakawa; Masato Tominaga; Hajime Arai
Journal:  Ann Nucl Med       Date:  2016-07-14       Impact factor: 2.668

2.  18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas.

Authors:  Anna Karlberg; Erik Magnus Berntsen; Håkon Johansen; Anne Jarstein Skjulsvik; Ingerid Reinertsen; Hong Yan Dai; Yiming Xiao; Hassan Rivaz; Per Borghammer; Ole Solheim; Live Eikenes
Journal:  Clin Nucl Med       Date:  2019-07       Impact factor: 7.794

3.  Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.

Authors:  Norbert Galldiks; Maximilian Niyazi; Anca L Grosu; Martin Kocher; Karl-Josef Langen; Ian Law; Giuseppe Minniti; Michelle M Kim; Christina Tsien; Frederic Dhermain; Riccardo Soffietti; Minesh P Mehta; Michael Weller; Jörg-Christian Tonn
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

4.  Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial.

Authors:  Toshihiko Wakabayashi; Toshihiko Iuchi; Naohiro Tsuyuguchi; Ryo Nishikawa; Yoshiki Arakawa; Takashi Sasayama; Keisuke Miyake; Tadashi Nariai; Yoshitaka Narita; Naoya Hashimoto; Osamu Okuda; Hiroshi Matsuda; Kazuo Kubota; Kimiteru Ito; Yoichi Nakazato; Kan Kubomura
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

5.  18F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling.

Authors:  Fraser Henderson; Steven Brem; Donald M O'Rourke; MacLean Nasrallah; Vivek P Buch; Anthony J Young; Robert K Doot; Austin Pantel; Arati Desai; Stephen J Bagley; S Ali Nabavizadeh
Journal:  Neurooncol Pract       Date:  2019-12-08
  5 in total
  1 in total

1.  Exploratory Analysis of Serial 18F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for Glioblastoma.

Authors:  Kavi Fatania; Russell Frood; Marcus Tyyger; Garry McDermott; Sharon Fernandez; Gary C Shaw; Marjorie Boissinot; Daniela Salvatore; Luisa Ottobrini; Irvin Teh; John Wright; Marc A Bailey; Joanna Koch-Paszkowski; Jurgen E Schneider; David L Buckley; Louise Murray; Andrew Scarsbrook; Susan C Short; Stuart Currie
Journal:  Cancers (Basel)       Date:  2022-07-18       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.